A Qualitative Exploration of Providers' Approaches to Relational Harm Reduction in HIV Primary Care Settings

Overview

Journal Res Sq

Date 2024 Apr 8

PMID 38586007

Authors

Emma Sophia Kay

Stephanie Creasy

Jessica Townsend

Mary Hawk

Affiliations

Soon will be listed here.

Abstract

Background: Structural harm reduction is an approach to care for people who use drugs (PWUD) that incorporates services and resources (e.g., naloxone, sterile syringes). As conceptualized in our previous research, harm reduction is also "relational," encompassing a patient-provider relationship that is non-judgmental and respectful of patients' autonomy. Little is known about providers' knowledge or attitudes towards harm reduction beyond structural strategies, whose availability and legality vary across geographical settings. To operationalize how relational harm reduction is both characterized and employed in HIV care settings, where nearly half of patients have a diagnosed substance use disorder, we qualitatively explored providers' knowledge of and use of harm reduction via individual in-depth interviews.

Methods: Our study sample included three HIV clinics, one in Birmingham, Alabama (AL) and two in Pittsburgh, Pennsylvania (PA). We conducted individual interviews with n = 23 providers via Zoom, using a semi-structured interview guide to probe for questions around providers' attitudes towards and experiences with providing care to PWH who use drugs and their knowledge of and attitudes towards relational and structural harm reduction. Data was analyzed in Dedoose using thematic analysis.

Results: Qualitative analyses revealed three primary themes, including . Nearly all providers (n = 19, 83%) described a patient interaction or expressed a sentiment that corresponded with the principles of relational harm reduction. Yet, over half of participants (n = 14, 61%) used language to describe PWH who use drugs that was stigmatizing or described an interaction that was antithetical to the principles of relational harm reduction. Five providers, all from Birmingham, were unaware of the term 'harm reduction.' Few providers had any harm reduction training.

Conclusion: Our findings suggest that relational harm reduction in HIV care settings is practiced along a continuum, and that a range of behaviors exist even within individual providers (e.g., used stigmatizing terms such as "addict" but also described patient interactions that reflected patients' autonomy). Given that harm reduction is typically described as a structural approach, a broader definition of harm reduction that is not dependent on policy-dependent resources is needed.

References

Chang J, Lindenfeld Z, Hagan H . Integrating Harm Reduction into Medical Care: Lessons from Three Models. J Am Board Fam Med. 2023; 36(3):449-461. PMC: 10636714. DOI: 10.3122/jabfm.2022.220303R3. View

Hartzler B, Dombrowski J, Crane H, Eron J, Geng E, Mathews W . Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. AIDS Behav. 2016; 21(4):1138-1148. PMC: 6089366. DOI: 10.1007/s10461-016-1584-6. View

Graham J, Shahani L, Grimes R, Hartman C, Giordano T . The Influence of Trust in Physicians and Trust in the Healthcare System on Linkage, Retention, and Adherence to HIV Care. AIDS Patient Care STDS. 2015; 29(12):661-7. PMC: 4684652. DOI: 10.1089/apc.2015.0156. View

King C, Collins D, Patten A, Nicolaidis C, Englander H . Trust in Hospital Physicians Among Patients With Substance Use Disorder Referred to an Addiction Consult Service: A Mixed-methods Study. J Addict Med. 2021; 16(1):41-48. PMC: 8349928. DOI: 10.1097/ADM.0000000000000819. View

Frankeberger J, Gagnon K, Withers J, Hawk M . Harm Reduction Principles in a Street Medicine Program: A Qualitative Study. Cult Med Psychiatry. 2022; 47(4):1005-1021. PMC: 9560723. DOI: 10.1007/s11013-022-09807-z. View

Blackstock O, Addison D, Brennan J, Alao O . Trust in primary care providers and antiretroviral adherence in an urban HIV clinic. J Health Care Poor Underserved. 2012; 23(1):88-98. DOI: 10.1353/hpu.2012.0006. View

Beane S, Culyba R, DeMayo M, Armstrong W . Exploring the medical home in Ryan White HIV care settings: a pilot study. J Assoc Nurses AIDS Care. 2014; 25(3):191-202. PMC: 4104981. DOI: 10.1016/j.jana.2013.10.007. View

Flickinger T, Saha S, Roter D, Korthuis P, Sharp V, Cohn J . Respecting patients is associated with more patient-centered communication behaviors in clinical encounters. Patient Educ Couns. 2015; 99(2):250-5. PMC: 5271348. DOI: 10.1016/j.pec.2015.08.020. View

Chan Carusone S, Guta A, Robinson S, Tan D, Cooper C, OLeary B . "Maybe if I stop the drugs, then maybe they'd care?"-hospital care experiences of people who use drugs. Harm Reduct J. 2019; 16(1):16. PMC: 6373073. DOI: 10.1186/s12954-019-0285-7. View

10.

Kosakowski S, Benintendi A, Lagisetty P, Larochelle M, Bohnert A, Bazzi A . Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering. J Gen Intern Med. 2022; 37(7):1722-1728. PMC: 9130417. DOI: 10.1007/s11606-021-07210-9. View

11.

Jaibat L, Cui Z, Mitra S, Loh J, Reddon H, Fairbairn N . Perceived Mistreatment in Health Care Settings and its Relationship with HIV Clinical Outcomes in HIV-positive People who Use Drugs in Vancouver, Canada. AIDS Behav. 2022; 27(5):1636-1646. PMC: 10149567. DOI: 10.1007/s10461-022-03895-z. View

12.

Lanham H, Papac J, Olmos D, Heydemann E, Simonetti N, Schmidt S . Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver. JAMA Netw Open. 2022; 5(5):e2212419. PMC: 9099423. DOI: 10.1001/jamanetworkopen.2022.12419. View

13.

Lesko C, Tong W, Moore R, Lau B . Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort. AIDS Behav. 2016; 21(4):1016-1024. PMC: 5344751. DOI: 10.1007/s10461-016-1585-5. View

14.

Winograd R, Davis C, Niculete M, Oliva E, Martielli R . Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings. Subst Abus. 2017; 38(2):135-140. DOI: 10.1080/08897077.2017.1303424. View

15.

Hawk M, Coulter R, Egan J, Fisk S, Friedman M, Tula M . Harm reduction principles for healthcare settings. Harm Reduct J. 2017; 14(1):70. PMC: 5655864. DOI: 10.1186/s12954-017-0196-4. View

16.

Gugala E, Briggs O, Moczygemba L, Brown C, Hill L . Opioid harm reduction: A scoping review of physician and system-level gaps in knowledge, education, and practice. Subst Abus. 2022; 43(1):972-987. DOI: 10.1080/08897077.2022.2060423. View

17.

Suarez-Garcia I, Sobrino-Vegas P, Dalmau D, Rubio R, Iribarren J, Blanco J . Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality. Addiction. 2016; 111(7):1235-45. DOI: 10.1111/add.13348. View

18.

Biancarelli D, Biello K, Childs E, Drainoni M, Salhaney P, Edeza A . Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019; 198:80-86. PMC: 6521691. DOI: 10.1016/j.drugalcdep.2019.01.037. View

19.

Beach M, Keruly J, Moore R . Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?. J Gen Intern Med. 2006; 21(6):661-5. PMC: 1924639. DOI: 10.1111/j.1525-1497.2006.00399.x. View

20.

Eaton L, Earnshaw V, Maksut J, Thorson K, Watson R, Bauermeister J . Experiences of stigma and health care engagement among Black MSM newly diagnosed with HIV/STI. J Behav Med. 2018; 41(4):458-466. PMC: 6031458. DOI: 10.1007/s10865-018-9922-y. View